{"id":333590,"date":"2026-08-10T17:52:20","date_gmt":"2026-08-10T17:52:20","guid":{"rendered":"https:\/\/www.europesays.com\/se\/333590\/"},"modified":"2026-08-10T17:52:20","modified_gmt":"2026-08-10T17:52:20","slug":"verkstadsbolag-i-taten-pa-stockholmsborsen","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/333590\/","title":{"rendered":"Verkstadsbolag i t\u00e4ten p\u00e5 Stockholmsb\u00f6rsen"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\"> Mycket fokus ligger fortsatt p\u00e5 samtalen om kriget i Iran.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Omkring klockan 12.15 hade storbolagsindexet OMXS30 sjunkit 0,1 procent till niv\u00e5n 3.308. Aktier f\u00f6r 9,2 miljarder kronor var d\u00e5 omsatta p\u00e5 Stockholmsb\u00f6rsen i sin helhet.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Ute i Europa var tyska DAX-indexet 0,3 procent h\u00f6gre medan franska CAC40 noterades of\u00f6r\u00e4ndrad.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Verkstads- och gruvrelaterade bolag hade b\u00e4st utveckling inom storbolagsindexet. Sandvik, ABB, Boliden och Epiroc steg 0,9-1,7 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">I andra \u00e4nden av indexet handlades teknikhandelsf\u00f6retaget Addtech och industrikonglomeratet Lifco ned 1,8 respektive 1,3 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Nyhetsfl\u00f6det domineras av det oklara l\u00e4get mellan USA och Iran. Iran har presenterat en ny kravlista och vill bland annat att USA h\u00e4ver blockaden av hamnar och tar bort sanktioner. Enligt Iran p\u00e5g\u00e5r inga f\u00f6rhandlingar men l\u00e4nderna uppges samtala via ombud. Oljepriserna har stigit n\u00e5got och Nordsj\u00f6oljan Brent handlades vid lunchtid kring 84 dollar per fat.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Raysearch Laboratories, en underleverant\u00f6r till str\u00e5lterapisektorn, har sett vad bolaget sj\u00e4lva beskriver som en &#8221;stark orderutveckling i USA under inledningen av tredje kvartalet&#8221;. Aktien adderade 6,7 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Lucara Diamond steg 2,3 procent efter att nettoresultatet f\u00f6r det andra kvartalet 2026 \u00f6kade och prognoserna f\u00f6r hel\u00e5ret upprepades. Diamantbolagets int\u00e4kter minskade n\u00e5got under perioden.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Nolato, som tillverkar produkter i polymera material, f\u00f6rv\u00e4rvar irl\u00e4ndska M&amp;M Qualtech. Bolaget \u00e4r verksamt inom elektronik och har en uppskattad \u00e5rsoms\u00e4ttning p\u00e5 cirka 385 miljoner kronor. F\u00f6rv\u00e4rvet v\u00e4ntas st\u00e4rka Nolatos position inom medicinteknik, industri och f\u00f6rsvar. Aktien var l\u00e4tt upp 0,4 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Specialistl\u00e4kemedelsbolaget Sobi inlicensierar l\u00e4kemedelskandidaten lacutamab vid behandling av T-cellslymfom fr\u00e5n Innate Pharma. Sobi betalar 75 miljoner dollar vid tilltr\u00e4det. Aktien kom av sig n\u00e5got fr\u00e5n m\u00e5ndagens inledande uppg\u00e5ng och var vid lunchtid endast upp 0,1 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Vidare har Pareto h\u00f6jt riktkursen f\u00f6r Yubico till 110 fr\u00e5n 70 kronor med upprepad k\u00f6prekommendation. Aktien som har stigit kraftigt sedan rapporten i torsdags var upp 0,3 procent till 88:95 kronor.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Graf: OMXS30 m\u00e5ndagen den 10 augusti<\/p>\n<p><a class=\"text-primary-90 hover:text-primary-110 underline hover:no-underline\" rel=\"noopener noreferrer\" target=\"_blank\" href=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2026\/08\/658672801.png\"><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2026\/08\/658672801.png\" alt=\"image\" class=\"rounded-2xl max-w-full\"\/><\/a><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">K\u00e4lla: Infront<\/p>\n","protected":false},"excerpt":{"rendered":"Mycket fokus ligger fortsatt p\u00e5 samtalen om kriget i Iran. Omkring klockan 12.15 hade storbolagsindexet OMXS30 sjunkit 0,1&hellip;\n","protected":false},"author":2,"featured_media":333591,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[5],"tags":[4993,5830,6171,22,23,6108,6136,26,27,17,21,24,25,5884,15766,28,29,15,6161,16,6714,18,6436,34,31,33,32,30,11925,19,20,827],"class_list":["post-333590","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rubriker","tag-abb","tag-addtech","tag-boliden","tag-breaking-news","tag-breakingnews","tag-epiroc","tag-epiroc-a","tag-featured-news","tag-featurednews","tag-headlines","tag-huvudnyheter","tag-latest-news","tag-latestnews","tag-lifco","tag-lucara-diamond","tag-main-news","tag-mainnews","tag-news","tag-nolato","tag-nyheter","tag-raysearch","tag-rubriker","tag-sandvik","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-swedish-orphan-biovitrum","tag-top-stories","tag-topstories","tag-yubico"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/117072491328545508","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/333590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=333590"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/333590\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/333591"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=333590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=333590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=333590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}